Coldstream Laboratories appoints vp of manufacturing

Dr Vickie Hall takes responsibility for manufacturing, facilities and warehouse operations

Coldstream Laboratories, a US provider of drug product research and manufacturing services, has named Dr Vickie Hall as vice president of manufacturing.

In her new position, Hall will assume responsibility of Coldstream's manufacturing, facilities, and warehouse operations in Lexington, Kentucky.

Hall brings to Coldstream more than 20 years of experience in managing research, product development, manufacturing and operations for vaccines and pharmaceuticals. Most recently, she served as executive director of manufacturing science and technology at Ben Venue Laboratories, a subsidiary of the Boehringer Ingelheim Corporation.

You may also like

Manufacturing

Piramal acquires Coldstream Laboratories for US$30.65m

Kentucky based CDMO specialises in sterile liquid and freeze-dried parenterals and injectables
Regulatory

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Manufacturing

Roquette opens pharmaceutical innovation centre in Brazil

The Health & Pharma Solutions facility in São Paolo offers state-of-the-art laboratories for customers, with the Northeast Center for Strategic Technologies partnering with Roquette to empower young women to pursue careers in science through the Futuras Cientistas programme at the facility
Manufacturing

RHEOFREED: A game-changing innovation in lyophilization technology

Dec Group announces its partnership with Kobelco Eco Solutions, Japan, and presents RHEOFREED®, a revolutionary mixer-type freeze dryer at CPHI Frankfurt 2025
Manufacturing

Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours

The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio
Manufacturing

Merck breaks ground on $3bn US manufacturing centre

The 400,000 sqft Elkton expansion forms part of Merck’s $70bn US investment plan to bolster domestic pharmaceutical manufacturing and R&D, creating more than 500 new full-time roles
Research & Development

AlzeCure Pharma publishes response letter clarifying Alzstatin’s distinct mechanism in Alzheimer’s treatment

AlzeCure Pharma and leading academic collaborators have published a response in JPET addressing recent commentary on Alzstatin’s γ-secretase modulation data, reaffirming the promise of lead candidate ACD680 in Alzheimer’s therapy
Subscribe now